Age-related differences in presentation and course of inflammatory bowel disease: An update on the population-based literature

Journal of Crohn's and Colitis

Volumn 8, Issue 11, 2014, Pages 1351-1361

  Duricova, Dana ^a   Burisch, Johan ^b   Jess, Tine ^c   Gower Rousseau, Corinne ^d   Lakatos, Peter L ^e  

^a CHARLES UNIVERSITY   (Czech Republic)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d UNIV LILLE   (France)

^e SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Age at onset; ; Disease phenotype; ; Incidence; ; Inflammatory bowel disease; ; Mortality; Surgery;

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; METHOTREXATE; STEROID; TUMOR NECROSIS FACTOR INHIBITOR;

ABDOMINAL SURGERY; AGE DISTRIBUTION; CANCER RISK; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CROHN DISEASE; ENTERIC FEEDING; HISTORY; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; INTESTINE CANCER; INTESTINE RESECTION; INTESTINE SURGERY; META ANALYSIS (TOPIC); MORTALITY; ONSET AGE; PHENOTYPE; POPULATION; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS; COLITIS, ULCERATIVE; DISEASE COURSE; INTESTINAL NEOPLASMS; RISK FACTOR;

AGE OF ONSET; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE PROGRESSION; HUMANS; INCIDENCE; INTESTINAL NEOPLASMS; PHENOTYPE; RISK FACTORS;

EID: 84927798221     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.05.006     Document Type: Review

References (85)

1. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 2002, 347:417-429.
2. Sartor R.B. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008, 134:577-594.
3. Chouraki V., Savoye G., Dauchet L., Vernier-Massouille G., J.L.Dupas, Merle V., et al. The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther 2011, 33:1133-1142.
4. Vernier-Massouille G., Balde M., Salleron J., Turck D., Dupas J.L., Mouterde O., et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology 2008, 135:1106-1113.
5. Benchimol E.I., Fortinsky K.J., Gozdyra P., Van den Heuvel M., Van Limbergen J., Griffiths A.M., et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011, 17:423-439.
6. Lakatos P.L., David G., Pandur T., Erdelyi Z., Mester G., Balogh M., et al. IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008. J Crohns Colitis 2011, 5:5-13.
7. Denson L.A. The role of the innate and adaptive immune system in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2013, 19:2011-2020.
8. Avitzur Y., Guo C., Mastropaolo L.A., Bahrami E., Chen H., Zhao Z., et al. Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. Gastroenterology 2014 Apr, 146(4):1028-1039.
9. Glocker E.O., Kotlarz D., Boztug K., Gertz E.M., Schäffer A.A., Noyan F., et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009 Nov 19, 361(21):2033-2045.
10. Malmborg P., Grahnquist L., Lindholm J., Montgomery S., Hildebrand H., et al. Increasing incidence of paediatric inflammatory bowel disease in northern Stockholm County, 2002-2007. J Pediatr Gastroenterol Nutr 2013, 57:29-34.
11. Molinie F., Gower-Rousseau C., Yzet T., Merle V., Grandbastien B., Marti R., et al. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut 2004, 53:843-848.
12. Cosnes J., Gower-Rousseau C., Seksik P., Cortot A., et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011, 140:1785-1794.
13. Molodecky N.A., Soon I.S., Rabi D.M., Ghali W.A., Ferris M., Chernoff G., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142:46-54.
14. Charpentier C., Salleron J., Savoye G., Fumery M., Merle V., Laberenne J.E., et al. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut 2014, 63:423-432.
15. Crocco S., Martelossi S., Giurici N., Villanacci V., Ventura A., et al. Upper gastrointestinal involvement in paediatric onset Crohn's disease: prevalence and clinical implications. J Crohns Colitis 2012, 6:51-55.
16. Burisch J., Pedersen N., Cukovic-Cavka S., Brinar M., Kaimakliotis I., Duricova D., et al. East-west gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2014, 63:588-597.
17. Vind L., Riis T., Jess E., Knudsen N., Pedersen M., Elkjaer, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006, 101:1274-1282.
18. Lakatos L., Kiss L.S., David G., Pandur T., Erdelyi Z., Mester G., et al. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflamm Bowel Dis 2011, 17:2558-2565.
19. Langholz E., Munkholm P., Nielsen O.H., Kreiner S., Binder V., et al. Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 1991, 26:1247-1256.
20. Munkholm P., Langholz E., Nielsen O.H., Kreiner S., Binder V., et al. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol 1992, 27:609-614.
21. Shivananda S., Lennard-Jones J., Logan R., Fear N., Price A., Carpenter L., et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996, 39:690-697.
22. Björnsson S., Jóhannsson J.H. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol 2000, 12:31-38.
23. Moum B., Vatn M.H., Ekbom A., Aadland E., Fausa O., Lygren I., et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996, 31:362-366.
24. Loftus C.G., Loftus E.V., Harmsen W.S., Harmsen A.R., Tremaine W.J., Melton 3rd L.J., et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007, 13:254-261.
25. Langholz E., Munkholm P., Krasilnikoff P.A., Binder V., et al. Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol 1997, 32:139-147.
26. Jakobsen C., Paerregaard A., Munkholm P., Faerk J., Lange A., Andersen J., et al. Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: a prospective population-based cohort study 2007-2009. Inflamm Bowel Dis 2011, 17:2541-2550.
27. Auvin S., Molinié F., Gower-Rousseau C., Brazier F., Merle V., Grandbastien B., et al. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999). J Pediatr Gastroenterol Nutr 2005, 41:49-55.
28. Gower-Rousseau C., Vasseur F., Fumery M., Savoye G., Salleron J., Dauchet L., et al. Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis 2013, 45:89-94.
29. Burisch J., Jess T., Martinato M., Lakatos P.L., ECCO-EpiCom The burden of inflammatory bowel disease in Europe. J Crohns Colitis 2013, 7:322-337.
30. Lovasz B.D., Lakatos L., Horvath A., Pandur T., Erdelyi Z., Balogh M., et al. Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011. Dig Liver Dis May 2014, 65(5):405-411.
31. Müller K.E., Lakatos P.L., Arato A., Kovács J.B., Várkonyi A., Szcs D., et al. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013, 57:576-582.
32. Pigneur B., Seksik P., Viola S., Viala J., Beaugerie L., Girardet J.P., et al. Natural history of Crohn's disease: comparison between childhood- and adult-onset disease. Inflamm Bowel Dis 2010, 16:953-961.
33. Freeman H.J. Long-term prognosis of early-onset Crohn's disease diagnosed in childhood or adolescence. Can J Gastroenterol 2004, 18:661-665.
34. Lovasz B.D., Lakatos L., Horvath A., Szita I., Pandur T., Mandel M., et al. Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort. World J Gastroenterol 2013, 19:2217-2226.
35. Burisch J. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort. Dan Med J 2014, 61:B4778.
36. Kariyawasam V.C., Gray T., Byth K., George J., Douglas M.W. Natural history of elderly onset inflammatory bowel disease - Sydney IBD cohort (1942-2012). Mo1314. Gastroenterology 2013, 144(5 Suppl. 1).
37. Gower-Rousseau C., Dauchet L., Vernier-Massouille G., Tilloy E., Brazier F., Merle V., et al. The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol 2009, 104:2080-2088.
38. Hyams J.S., Davis P., Grancher K., Lerer T., Justinich C.J., Markowitz J., et al. Clinical outcome of ulcerative colitis in children. J Pediatr 1996, 129:81-88.
39. Magro F., Rodrigues A., Vieira A.I., Portela F., Cremers I., Cotter J., et al. Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts. Inflamm Bowel Dis 2012, 18:573-583.
40. Turner D., Levine A., Escher J.C., Griffiths A.M., Russell R.K., Dignass A., et al. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr 2012, 55:340-361.
41. Dignass A., Van Assche G., Lindsay J.O., Lémann M., Söderholm J., Colombel J.F., et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis 2010, 4:28-62.
42. Markowitz J., Grancher K., Kohn N., Lesser M., Daum F. A multicenter trial of 6- mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000, 119:895-902.
43. Dziechciarz P., Horvath A., Shamir R., Szajewska H. Meta-analysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther 2007, 26:795-806.
44. Zachos M., Tondeur M., Griffiths A.M. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2007, 1:CD000542.
45. Lakatos P.L., Golovics P.A., David G., Pandur T., Erdelyi Z., Horvath A., et al. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. Am J Gastroenterol 2012, 107:579-588.
46. Benchimol E.I., Guttmann A., To T., Rabeneck L., Griffiths A.M. Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994-2007). Inflamm Bowel Dis 2011, 17:2153-2161.
47. Adamiak T., Walkiewicz-Jedrzejczak D., Fish D., Brown C., Tung J., Khan K., et al. Incidence, clinical characteristics, and natural history of pediatric inflammatory bowel disease in Wisconsin: a population-based epidemiological study. Inflamm Bowel Dis 2013, 19:1218-1223.
48. Heresbach D., Alexandre J.L., Bretagne J.F., Cruchant E., Dabadie A., Dartois-Hoguin M., et al. Crohn's disease in the over-60 age group: a population based study. Eur J Gastroenterol Hepatol 2004, 16:657-664.
49. Jakobsen C., Bartek J., Wewer V., Vind I., Munkholm P., Groen R., et al. Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease-a population-based study. Aliment Pharmacol Ther 2011, 34:1217-1224.
50. Stordal K., Jahnsen J., Bentsen B.S., Moum B. Pediatric inflammatory bowel disease in southeastern Norway: a five-year follow-up study. Digestion 2004, 70:226-230.
51. Turunen P., Kolho K.L., Auvinen A., Iltanen S., Huhtala H., Ashorn M. Incidence of inflammatory bowel disease in Finnish children, 1987-2003. Inflamm Bowel Dis 2006, 12:677-683.
52. Langholz E., Munkholm P., Davidsen M., Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992, 103:1444-1451.
53. Moum B., Ekbom A., Vatn M.H., Aadland E., Sauar J., Lygren I., et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol 1997, 32:1005-1012.
54. Romberg-Camps M.J., Dagnelie P.C., Kester A.D., Hesselink-van de Kruijs M.A., Cilissen M., Engels L.G., et al. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol 2009, 104:371-383.
55. Solberg I.C., Lygren I., Jahnsen J., Aadland E., Høie O., Cvancarova M., et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 2007, 5:1430-1438.
56. Leijonmarck C.E., Persson P.G., Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990, 31:329-333.
57. Solberg I.C., Lygren I., Jahnsen J., Aadland E., Høie O., Cvancarova M., et al. Clinical course during the first 10years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009, 44:431-440.
58. Ekbom A., Helmick C., Zack M., Adami H.O. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990, 323:1228-1233.
59. Munkholm P. Crohn's disease-occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull 1997, 44:287-302.
60. Karlen P., Lofberg R., Brostrom O., Leijonmarck C.E., Hellers G., Persson P.G., et al. Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol 1999, 94:1047-1052.
61. Winther K.V., Jess T., Langholz E., Munkholm P., Binder V. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2004, 2:1088-1095.
62. Jess T., Winther K.V., Munkholm P., Langholz E., Binder V. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther 2004, 19:287-293.
63. Winther K.V., Jess T., Langholz E., Munkholm P., Binder V. Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County. Gastroenterology 2003, 125:1576-1582.
64. Jess T., Winther K.V., Munkholm P., Langholz E., Binder V. Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Gastroenterology 2002, 122:1808-1814.
65. Jess T., Gamborg M., Matzen P., Munkholm P., Sørensen T.I. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 2005, 100:2724-2729.
66. Jess T., Simonsen J., Jorgensen K.T., Pedersen B.V., Nielsen N.M., Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30years. Gastroenterology 2012, 143:375-381.
67. Jess T., Horvath-Puho E., Fallingborg J., Rasmussen H.H., Jacobsen B.A. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study. Am J Gastroenterol 2013, 108:1869-1876.
68. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
69. Jess T., Rungoe C., Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 2012, 10:639-645.
70. Jess T., Loftus E.V., Velayos F.S., Harmsen W.S., Zinsmeister A.R., Smyrk T.C., et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted county, Minnesota. Gastroenterology 2006, 130:1039-1046.
71. Bernstein C.N., Blanchard J.F., Kliewer E., Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001, 91:854-862.
72. Soderlund S., Brandt L., Lapidus A., Karlén P., Broström O., Löfberg R., et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology 2009, 136:1561-1567.
73. Peneau A., Savoye G., Turck D., Dauchet L., Fumery M., Salleron J., et al. Mortality and cancer in pediatric-onset inflammatory bowel disease: a population-based study. Am J Gastroenterol 2013, 108:1647-1653.
74. Jess T., Gamborg M., Munkholm P., Sørensen T.I. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol 2007, 102:609-617.
75. Jess T., Frisch M., Simonsen J. Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010. Clin Gastroenterol Hepatol 2013, 11:43-48.
76. Duricova D., Pedersen N., Elkjaer M., Gamborg M., Munkholm P., Jess T., et al. Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies. Inflamm Bowel Dis 2010, 16:347-353.
77. Wolters F.L., Russel M.G., Sijbrandij J., Schouten L.J., Odes S., Riis L., et al. Crohn's disease: increased mortality 10years after diagnosis in a Europe-wide population based cohort. Gut 2006, 55:510-518.
78. Jacobsen B.A., Fallingborg J., Rasmussen H.H., Nielsen K.R., Drewes A.M., Puho E., et al. Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002. Eur J Gastroenterol Hepatol 2006, 18:601-606.
79. Sincić B.M., Vucelić B., Persić M., Brncić N., Erzen D.J., Radaković B., et al. Incidence of inflammatory bowel disease in Primorsko-goranska County, Croatia, 2000-2004: a prospective population-based study. Scand J Gastroenterol 2006, 41:437-444.
80. Ekbom A., Helmick C., Zack M., Adami H.O. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991, 100:350-358.
81. Moum B., Vatn M.H., Ekbom A., Aadland E., Fausa O., Lygren I., et al. Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996, 31:355-361.
82. Rodrigo L., Riestra S., Niño P., Cadahía V., Tojo R., Fuentes D., et al. A population-based study on the incidence of inflammatory bowel disease in Oviedo (Northern Spain). Rev Esp Enferm Dig 2004, 96:296-305.
83. Romberg-Camps M.J., Hesselink-van de Kruijs M.A., Schouten L.J., Dagnelie P.C., Limonard C.B., Kester A.D., et al. Inflammatory bowel disease in South Limburg (the Netherlands) 1991-2002: incidence, diagnostic delay, and seasonal variations in onset of symptoms. J Crohns Colitis 2009, 3:115-124.
84. Tragnone A., Corrao G., Miglio F., Caprilli R., Lanfranchi G.A. Incidence of inflammatory bowel disease in Italy: a nationwide population-based study. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Int J Epidemiol 1996, 25:1044-1052.
85. Ott C., Obermeier F., Thieler S., Kemptner D., Bauer A., Schölmerich J., et al. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study. Eur J Gastroenterol Hepatol 2008, 20:917-923.